From Our Partners
Sunday, June 26, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home CBRNE

BARDA Announces CBRN Medical Countermeasures Conference

by Global Biodefense Staff
September 28, 2012

The Biomedical Advanced Research and Development Authority (BARDA) has announced an upcoming conference for industry to learn more about U.S. government medical countermeasure requirements, interact with BARDA, and network with other private sector colleagues. The event will take place Oct. 29-31 in Washington, D.C.

BARDA supports the advanced research & development, manufacturing, acquisition, and stockpiling of medical countermeasures against chemical, biological, radiological, and nuclear (CBRN) WMD threats, pandemic influenza, and emerging infectious diseases.

BARDA’s work is carried out as part of the Public Health Emergency Medical Countermeasure Enterprise (PHEMCE), a coordinated interagency effort that also includes three primary HHS agencies (NIH, FDA, and CDC), as well as the Departments of Homeland Security, Defense, Veteran’s Affairs, and Agriculture.

Included in the conference agenda is information on the 2012 PHEMCE Strategic Implementation Plan and its goals for medical countermeasure development, manufacturing, approval for use, and deployment; and discussion of new initiatives designed to encourage novel and innovative approaches to the development of countermeasures.

Conference participants may also request one-on-one meetings with BARDA program staff and Office of Acquisitions Management, Contracts and Grants (AMCG) contracting officers. Requests for such meetings should be submitted at the time of registration for the conference.

Conference registration is now available at www.medicalcountermeasures.gov

From Our Partners
Tags: ASPRBARDAEventsHHS

Related Posts

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control
Medical Countermeasures

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Biodefense Industry News
Industry News

Tonix Pharmaceuticals Opens Advanced Development Center for Vaccine Programs

June 20, 2022
BARDA and JPEO-CBRND Back Cepheid’s Multiplex Test for Influenza, SARS-CoV2 and RSV
Health Security

Resurgent COVID-19, Flu and Other Viruses are Pushing New Zealand’s Health System to the Limit

June 2, 2022
Monkeypox Cases Prompt Additional Contracts for Bavarian Nordic Vaccine
Medical Countermeasures

Monkeypox Cases Prompt Additional Contracts for Bavarian Nordic Vaccine

May 30, 2022
Load More

Latest News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Influenza Research

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC